- Home
- MDXG vs BCSF Comparison
MDXG vs BCSF Comparison
Compare MDXG & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- BCSF
- Stock Information
- Founded
- MDXG 2006
- BCSF 2015
- Country
- MDXG United States
- BCSF United States
- Employees
- MDXG N/A
- BCSF N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- BCSF Finance/Investors Services
- Sector
- MDXG Health Care
- BCSF Finance
- Exchange
- MDXG Nasdaq
- BCSF Nasdaq
- Market Cap
- MDXG 1.1B
- BCSF 983.4M
- IPO Year
- MDXG N/A
- BCSF 2018
- Fundamental
- Price
- MDXG $7.13
- BCSF $14.84
- Analyst Decision
- MDXG Buy
- BCSF Buy
- Analyst Count
- MDXG 1
- BCSF 2
- Target Price
- MDXG $12.00
- BCSF $16.50
- AVG Volume (30 Days)
- MDXG 450.7K
- BCSF 269.9K
- Earning Date
- MDXG 10-29-2025
- BCSF 11-04-2025
- Dividend Yield
- MDXG N/A
- BCSF 12.12%
- EPS Growth
- MDXG N/A
- BCSF N/A
- EPS
- MDXG 0.21
- BCSF 1.66
- Revenue
- MDXG $363,774,000.00
- BCSF $283,687,000.00
- Revenue This Year
- MDXG $12.68
- BCSF N/A
- Revenue Next Year
- MDXG $8.18
- BCSF N/A
- P/E Ratio
- MDXG $33.71
- BCSF $8.94
- Revenue Growth
- MDXG 6.85
- BCSF N/A
- 52 Week Low
- MDXG $5.47
- BCSF $13.20
- 52 Week High
- MDXG $10.14
- BCSF $19.21
- Technical
- Relative Strength Index (RSI)
- MDXG 52.83
- BCSF 38.79
- Support Level
- MDXG $6.89
- BCSF $14.51
- Resistance Level
- MDXG $7.14
- BCSF $14.91
- Average True Range (ATR)
- MDXG 0.18
- BCSF 0.24
- MACD
- MDXG -0.02
- BCSF -0.12
- Stochastic Oscillator
- MDXG 70.45
- BCSF 24.81
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.